EpiCapture Urine-Based Prostate Cancer Test Shows High Accuracy in Clinical Study
The updated urine test utilizes machine learning and patient ethnicity to provide individualized risk scores for aggressive disease.
Read MorePosted by CLP Edit Staff | Apr 6, 2026 | Prostate |
The updated urine test utilizes machine learning and patient ethnicity to provide individualized risk scores for aggressive disease.
Read MorePosted by CLP Edit Staff | Apr 6, 2026 | Molecular Diagnostics, Womens Health |
A peer-reviewed study suggests molecular signatures can be identified without invasive uterine sampling using whole-transcriptome sequencing and machine learning.
Read MorePosted by CLP Edit Staff | Apr 2, 2026 | Flow Cytometry Reagents & Test Kits |
Increased adoption of flow cytometry and artificial intelligence tools helps clinicians manage the rising number of indeterminate pulmonary nodules.
Read MorePosted by CLP Edit Staff | Apr 2, 2026 | Prostate |
A new study validates a machine-learning platform that detects prostate cancer through biochemical patterns in urine samples.
Read MorePosted by CLP Edit Staff | Mar 30, 2026 | Cancer, Disease States, Hematology & Serology |
A Mayo Clinic study of 674 trauma patients found elevated circulating nucleosome levels in those who developed venous thromboembolism, suggesting a potential new biomarker for early VTE risk identification.
Read More